Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Am Heart J. 2021 Jun 20;240:63–72. doi: 10.1016/j.ahj.2021.06.007

Table III:

Unadjusted 60-day Outcomes of Analysis 1: SOT-IE vs Non-SOT-IE

Overall (Weighted N = 193,164) SOT-IE (Weighted N = 1,574) Non-SOT-IE (Weighted N = 191,590) p-value
Mean (SD) or N (%)
Death 30,583 (15.8) 271 (17.2) 30,312 (15.8) 0.33
ECMO deployed * * 964 (0.5) 0.56
Mechanical ventilation 44,840 (23.2) 375 (23.8) 44,465 (23.2) 0.71
Thromboembolic event 67,836 (35.1) 348 (22.1) 67,488 (35.2) <0.001
Length of stay (days) 21.3 (20.3) 21.6 (21.4) 21.3 (20.3) 0.73
Total Costs ($ Thousands) 58.4 (68.6) 65.9 (76.0) 58.4 (68.5) 0.06
Valve Repair or Replacement 31,270 (16.2) 196 (12.5) 31,074 (16.2) 0.007

P-values by weighted linear regression for continuous variables and weighted chi2 test for binary/categorical variables

SOT, solid organ transplant; IE, infective endocarditis; SD, standard deviation; N, number; ECMO, extracorporeal membrane oxygenation

*

N < 10; exact number suppressed to comply with restrictions of data vendor.